An initial event in the keratinization of squamous epithelial cells is the deposition of a protein layer 15 nm thick along the cytoplasmic face of the plasma membrane to form the cell envelope (CE). The stability of this highly resistant structure which, is essential for the protective function of the cornfield layer, is primarily due to the formation of epsilon-(gamma-glutamyl-lysine) bonds. Considerable data from numerous investigators suggest that CE have a high cystine content. Furthermore, dense homogeneous deposits, which have a sulfur-rich component, are thought to participate in the formation of CE. However, to date, conclusive data identifying this cystine-rich component has not been reported. Evidence is presented in this proposal for the isolation and characterization of a cDNA clone encoding a previously undescribed protein which is a major component of the CE. The high cystine content of this protein (6.9%) and its apparent localization with granules suggest that it may be the sulfur-rich component of dense homogeneous deposits. Transcripts of the gene encoding this protein, referred to as major cell envelope protein (MCEP), are restricted to the granular layer of the epidermis and are as abundant as those of the differentiation-specific keratins, K1 and K10, and filaggrin. Expression of the MCEP gene occurs, not only in the epidermis, but in all keratinizing squamous epithelia. In addition, immunological studies with antibodies elicited against a specific mouse MCEP peptide recognize conserved epitopes in man and all tested vertebrates. Thus, MCEP is highly conserved and, quantitatively, the most important CE component discovered to date. The major role played by this protein in CE formation and function makes the gene encoding it a likely target for mutation resulting in keratinization disorders. The genes encoding mouse and human MCEP will be isolated and sequenced. Due to deficiencies in existing cell culture systems, experiments designed to identify sequences responsible for tissue-, developmental-, and differentiation-specific expression of the MCEP gene must be performed in transgenic mice. After determining sequences important for appropriate expression, proteins interacting with these sequences will be characterized and the genes encoding these proteins will be cloned. Mutations designed to interface with the assembly of MCEP into CE, its function and expression will be introduced into the germline of mice to determine if defects in keratinization results. CE formed in transgenic mice containing mutant MCEP genes will be examined by ultrastructural electron microscopic methods to determine the process of assembly. Finally, existing mouse and human mutations exhibiting keratinization disorders will be examined to determine if there is direct involvement of the MCEP gene.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR040240-05
Application #
2079923
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1989-12-01
Project End
1994-11-30
Budget Start
1993-12-01
Budget End
1994-11-30
Support Year
5
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Jarnik, Michal; de Viragh, Pierre A; Scharer, Elisabeth et al. (2002) Quasi-normal cornified cell envelopes in loricrin knockout mice imply the existence of a loricrin backup system. J Invest Dermatol 118:102-9
Koch, P J; de Viragh, P A; Scharer, E et al. (2000) Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein. J Cell Biol 151:389-400
Suga, Y; Jarnik, M; Attar, P S et al. (2000) Transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin diseases, Vohwinkel syndrome and progressive symmetric erythrokeratoderma. J Cell Biol 151:401-12
DiSepio, D; Bickenbach, J R; Longley, M A et al. (1999) Characterization of loricrin regulation in vitro and in transgenic mice. Differentiation 64:225-35
Attar, P S; Wertz, P W; McArthur, M et al. (1997) Inhibition of retinoid signaling in transgenic mice alters lipid processing and disrupts epidermal barrier function. Mol Endocrinol 11:792-800
Bickenbach, J R; Greer, J M; Bundman, D S et al. (1995) Loricrin expression is coordinated with other epidermal proteins and the appearance of lipid lamellar granules in development. J Invest Dermatol 104:405-10
DiSepio, D; Jones, A; Longley, M A et al. (1995) The proximal promoter of the mouse loricrin gene contains a functional AP-1 element and directs keratinocyte-specific but not differentiation-specific expression. J Biol Chem 270:10792-9
Imakado, S; Bickenbach, J R; Bundman, D S et al. (1995) Targeting expression of a dominant-negative retinoic acid receptor mutant in the epidermis of transgenic mice results in loss of barrier function. Genes Dev 9:317-29
Rothnagel, J A; Longley, M A; Bundman, D S et al. (1994) Characterization of the mouse loricrin gene: linkage with profilaggrin and the flaky tail and soft coat mutant loci on chromosome 3. Genomics 23:450-6
Greenhalgh, D A; Rothnagel, J A; Roop, D R (1994) Epidermis: an attractive target tissue for gene therapy. J Invest Dermatol 103:63S-69S

Showing the most recent 10 out of 16 publications